Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
05/2007
05/22/2007US7220756 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands
05/22/2007US7220738 Rifamycin analogs and uses thereof
05/16/2007EP1063237B1 Method for preparing metal complex of porphyrin
05/16/2007CN1965052A Single-layer organic el device
05/16/2007CN1315832C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives
05/16/2007CN1315827C 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
05/15/2007US7217721 8-Azabicyclo[3.2.1]octane derivatives of 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridines, used for modulating chemokine CCR5 receptors for treating retroviral infections and inflammatory diseases
05/15/2007US7217716 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate NR2B antagonists
05/15/2007US7217465 For use in light-emitting device; can be easily applied to vacuum vapor deposition and exhibit long wavelength light
05/15/2007CA2374767C Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
05/10/2007WO2007053353A2 Pyrrolo[2,3-f] and [3,2-f]isoquinolinone derivatives as 5-hydroxytryptamine-6 ligands
05/10/2007WO2007051630A1 Heterocyclic compounds and their use as antifouling agents
05/10/2007US20070105784 Substituted quinolines for the treatment of cancer
05/09/2007EP1783128A1 Heterocyclic compounds and their use as antifouling agents
05/09/2007EP1781658A1 Imidazoý4,5-d¨pyrimidines, their uses and methods of preparation
05/09/2007EP1599478B1 Dihydropteridinones, method for the production and use thereof in the form of drugs
05/09/2007EP1183245B1 Selective npy (y5) antagonists
05/09/2007CN1958588A Synthesis of a kind of compound of new beta ¿C octamethylporphyrin, and application
05/09/2007CN1314739C Composition stabilized against thermal, oxidative or light-induced degradation and its preparing process
05/03/2007US20070099904 Pharmaceutical composition for the treatment of cns and other disorders
05/03/2007US20070099899 Heterocyclic dihydropyrimidine compounds
05/03/2007US20070099871 Bioreductively-activated prodrugs
05/03/2007US20070098643 Oligomers of gadolinium chelates, their applicationascontrast products in magnetic resonance imaging and their synthesis intermediates
05/02/2007EP1778697A1 Substituted bicyclic 8-pyrrolidino-xanthines and use thereof as inhibitors of the dipeptidyl peptidase iv
05/02/2007EP1778677A1 Heterocyclic condensed compounds useful as antidiuretic agents
05/02/2007EP1480979B1 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates
05/02/2007EP1451197B1 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-[3.2.2]-nonane derivatives, preparation and therapeutic use thereof
05/02/2007CN1956989A Purine derivative
05/02/2007CN1956988A Mono-, oligo- and polythieno[3,2-b]thiophenes
05/02/2007CN1955182A Purine compound and use as cannabinoid receptor ligands
05/02/2007CN1955181A Purine compound and use as cannabinoid receptor ligands
05/02/2007CN1955178A New benzimidazole derivative
05/01/2007US7211666 N-Cyclopropyl-4-[[5-[(methoxyamino)carbonyl]-2-methylphenyl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide; aminating with chloramine to produce a pyrrole with a Nitrogen nitrogen bond; reacting with formamide, cyclizing to form the pyrrolotriazine core; kinase inhibitors
04/2007
04/26/2007WO2007046809A1 Thieno-pyrimidine compounds having fungicidal activity
04/26/2007US20070093652 longer wavelength absorption than structurally similar dyes; staining; ligand and analyte detection; aromatic or heteroaromatic ring fused at 3,4-double bond; fluorescent dyes, chemically reactive dyes, dye-conjugates; use of such dyes in staining samples and detecting ligands
04/26/2007US20070093464 chemical intermediates for making an oral antibiotics Sulbactam
04/25/2007EP1776372A1 Substituted, bicyclic 8-pyrrolidinoxanthines, method for the production thereof and their use as medicaments
04/25/2007EP1436297B1 Photoactivable nitrogen bases
04/25/2007CN1953983A 1-heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones
04/25/2007CN1312154C Purine derivatives as kinase inhibitors
04/25/2007CN1312131C Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredent
04/24/2007US7208518 antiinflammatory agents; asthma; 2-hydroxy-3-(4-hydroxy-5-methyl-2-oxo-2H-chromene-3-yl)-9-methyl-2,3-dihydro-4H-furo[3,2-c]chromene-4-one; from 4-Hydroxycoumarin and glyoxal
04/24/2007US7208493 Vasculostatic agents and methods of use thereof
04/24/2007CA2166811C Tricyclic inhibitors of the gpiibiiia receptor
04/19/2007WO2007044426A2 Pyrazolopyrimidines as protein kinase inhibitors
04/19/2007US20070088025 Tricyclic 1-[(indol-3-yl)carbonyl]piperazine derivatives as cannabinoid cb1 receptor agonists
04/19/2007DE10212564B4 1-Allyl-ergotalkaloid-Derivate und ihre Verwendung zur Prophylaxe und Therapie von Migräne 1-allyl ergot alkaloid derivatives and their use for the prophylaxis and treatment of migraine
04/19/2007CA2624826A1 Pyrazolopyrimidines as protein kinase inhibitors
04/18/2007EP1775298A1 Thienopyrazole derivative having pde7 inhibitory activity
04/18/2007EP1775297A2 Adenosine receptor antagonists and methods of making and using the same
04/18/2007EP1773847A2 Antibacterial agents
04/18/2007EP1773834A2 2, 8-disubstituted naphthyridine derivatives
04/18/2007EP1451161B1 Imidazopyridines, pyrimidines and triazines for enhancing cognition as gaba-a alpha 5 receptor subtype ligands
04/18/2007CN1950374A Tetraazabenzo[e]azulene derivatives and analogs thereof
04/18/2007CN1950371A Tetrahydronaphthyridine derivatives useful as histamine h3 receptor ligands
04/18/2007CN1948310A 3 position substituted mesoazalene compounds and high efficiency synthesis method
04/18/2007CN1310914C Acid absorbing agent for preparing cinchona alkaloids ligand
04/17/2007US7205408 Therapy for bacteria infections in mammals
04/17/2007US7205332 Deoxoartemisinin analogs, process for their preparation, and anticancer agent comprising them
04/17/2007US7205105 Real-time linear detection probes: sensitive 5′-minor groove binder-containing probes for PCR analysis
04/17/2007US7205001 Anticancer agents; using potassium arsenite therapy and radiation
04/17/2007CA2386799C Fused cycloheptane and fused azacycloheptane compounds and their as integrin receptor antagonists
04/17/2007CA2190765C Novel potent inducers of terminal differentiation and methods of use thereof
04/12/2007WO2007041130A2 Deazapurines useful as inhibitors of janus kinases
04/12/2007US20070082883 HIV protease inhibitors
04/12/2007CA2623032A1 Deazapurines useful as inhibitors of janus kinases
04/11/2007EP1771450A2 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
04/11/2007EP1696930B1 Tricyclic 1-((3-indol-3-yl)carbonyl)piperazine derivatives as cannabinoid cb1 receptor agonists
04/11/2007EP1501838B1 A process for the preparation of clopidogrel
04/11/2007CN1946728A Process for isolation of ergot alkaloids from ergot
04/11/2007CN1946726A Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics
04/11/2007CN1309721C Beta-carboline derivatives and its pharmaceutical use against depression and anxiety
04/10/2007US7202238 Diazabicyclo alkane derivatives with NK1 antagonistic activity
04/05/2007WO2007037518A1 Mutilin derivative and pharmaceutical composition containing the same
04/05/2007WO2007036733A1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
04/04/2007CN1942479A Thienopyrroles as antagonists of GnRH
04/04/2007CN1308313C Fused azepine drivatives and their use as antidiuretic agents
03/2007
03/29/2007WO2007034817A1 Novel adenine compound
03/29/2007US20070072887 Spirofuropyridine aryl derivatives
03/28/2007EP1765830A1 Mitotic kinesin inhibitors
03/28/2007EP1765823A1 Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
03/28/2007EP1256581B1 Preventive or therapeutic agents for gastric or esophageal regurgitation
03/28/2007CN1938321A Novel compound and organic electronic device using such compound
03/28/2007CN1938303A Azaindoles useful as inhibitors of jak and other protein kinases
03/28/2007CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog
03/27/2007US7196364 Molecular device, molecule array, rectifier device, rectifying method, sensor device, switching device, circuit device, logical circuit device, operational device and information processing device
03/22/2007US20070066818 Method for preparing cucurbiturils
03/21/2007EP1764368A1 Antimitotic halogenated derivatives of Vinca alkaloids
03/21/2007CN1934100A Substituted quinazoline or pyridopyrimidine derivative
03/20/2007US7193237 Organic semiconductor material and organic electronic device
03/20/2007CA2142280C Metal-mediated cross-coupling with ring-metalated porphyrins
03/15/2007WO2007028460A1 TETRAHYDRO-β-CARBOLIN-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS
03/15/2007US20070060563 Quinuclidine derivatives binding to mucarinic m3 receptors
03/15/2007US20070057250 Light-emitting device, organic compound and display
03/15/2007CA2616729A1 Tetrahydro-.beta.-carbolin-sulfonamide derivatives as 5-ht6 ligands
03/14/2007CN1930169A Method for preparing compounds comprising cucurbituril groups
03/14/2007CN1930145A Cycloalkanopyridine derivative
03/14/2007CN1927867A Synthesis method of biapenem
03/13/2007US7189720 Selective NPY (Y5) antagonists
03/13/2007US7189710 C2-fluoro pyrrolo [2,1−c][1,4]benzodiazepine dimers
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 111